{
  "id": "5a9acd921d1251d03b000016",
  "type": "factoid",
  "question": "In what phase of clinical trials is crenezumab? (November 2017)",
  "ideal_answer": "Crenezumab is undergoing phase III clinical trials.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28720101"
  ],
  "snippets": [
    {
      "text": "Ongoing Phase III clinical trials via passive immunotherapy against A\u03b2 peptides (crenezumab, gantenerumab, and aducanumab) seem to be promising. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28720101",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Phase III"
}